Profile data is unavailable for this security.
About the company
AIM Vaccine Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of vaccine. The Company's products mainly include recombinant hepatitis B vaccine, human rabies vaccine, inactivated hepatitis A vaccine, mumps vaccine, inactivated hemorrhagic fever with renal syndrome vaccine and MPSV4. The Company's products are mainly used for the treatment of hepatitis B, hepatitis A, mumps, hemorrhagic fever with renal syndrome, rabies and meningococcal diseases. The Company's vaccine candidates include messenger RNA (mRNA) corona virus disease 2019 (COVID-19) vaccine, inactivated COVID-19 vaccine, broad-spectrum COVID-19 vaccine, PCV13, PPSV23 and MCV4. The Company principally conducts its businesses in the domestic market.
- Revenue in HKD (TTM)1.29bn
- Net income in HKD-1.30bn
- Incorporated2011
- Employees1.56k
- LocationAIM Vaccine Co Ltd25/FBuilding A, 91 Jianguo Road, ChaoyangBEIJING 110000ChinaCHN
- Phone+86 1 085950689
- Fax+86 1 085950063
- Websitehttps://www.aimbio.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shandong Boan Biotechnology Co Ltd | 786.30m | 67.51m | 4.88bn | 777.00 | 68.72 | 3.05 | 34.08 | 6.21 | 0.1326 | 0.1326 | 1.54 | 2.99 | 0.3069 | 1.10 | 2.60 | 967,157.30 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3369 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
Tong Ren Tang Technologies Co Ltd | 7.51bn | 710.87m | 6.54bn | 4.01k | 9.21 | 0.8444 | 4.60 | 0.8712 | 0.555 | 0.555 | 5.87 | 6.05 | 0.5026 | 0.9881 | 5.22 | 1,831,768.00 | 7.42 | 7.68 | 11.69 | 12.32 | 40.97 | 43.50 | 14.76 | 16.11 | 2.30 | -- | 0.1968 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
Sihuan Pharmaceutical Holdings Group Ltd | 1.92bn | -41.29m | 6.80bn | 2.65k | -- | 1.41 | -- | 3.55 | -0.0045 | -0.0045 | 0.2065 | 0.5182 | 0.1506 | 0.894 | 3.90 | 667,311.90 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.50 | -- | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
Beijing Tong Ren Tang Chinese Medicine | 1.38bn | 494.14m | 6.81bn | 779.00 | 13.77 | 1.79 | 11.01 | 4.94 | 0.5903 | 0.5903 | 1.64 | 4.55 | 0.3284 | 0.3554 | 3.62 | 1,725,133.00 | 12.72 | 16.71 | 14.09 | 18.75 | 72.06 | 69.88 | 38.72 | 40.72 | 9.55 | -- | 0.0327 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
Consun Pharmaceutical Group Ltd | 2.99bn | 913.63m | 6.99bn | 3.18k | 7.30 | 1.73 | 6.99 | 2.34 | 1.13 | 1.13 | 3.71 | 4.79 | 0.5209 | 2.00 | 12.89 | 956,784.40 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
China Shineway Pharmaceutical Group Ltd | 4.59bn | 1.21bn | 7.61bn | 3.23k | 5.76 | 0.9494 | 5.46 | 1.66 | 1.60 | 1.60 | 6.08 | 9.69 | 0.4476 | 1.28 | 5.26 | 1,336,654.00 | 11.76 | 8.03 | 15.47 | 9.77 | 75.21 | 74.55 | 26.27 | 17.87 | 3.14 | -- | 0.0457 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
Yichang Hec Changjiang Pharmactcl Co Ltd | 6.05bn | 1.80bn | 7.76bn | 4.89k | 4.31 | 0.82 | 3.71 | 1.28 | 2.05 | 2.05 | 6.88 | 10.76 | 0.4272 | 2.50 | 3.74 | 1,310,494.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 50.79 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
AIM Vaccine Co Ltd | 1.29bn | -1.30bn | 9.10bn | 1.56k | -- | 2.38 | -- | 7.03 | -1.07 | -1.07 | 1.07 | 3.16 | 0.1462 | 0.6325 | 1.10 | 796,494.10 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
Everest Medicines Ltd | 457.20m | -1.15bn | 10.25bn | 520.00 | -- | 2.10 | -- | 22.42 | -3.57 | -3.57 | 1.42 | 15.02 | 0.0756 | 5.23 | 3.22 | 1,058,327.00 | -19.03 | -30.52 | -20.21 | -33.14 | 75.74 | -- | -251.64 | -5,745.25 | 4.62 | -- | 0.1119 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
Luye Pharma Group Ltd | 6.90bn | 841.60m | 10.50bn | 5.23k | 12.47 | 0.738 | 6.20 | 1.52 | 0.2237 | 0.2237 | 1.83 | 3.78 | 0.236 | 2.44 | 3.02 | 1,308,626.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
SSY Group Ltd | 6.47bn | 1.37bn | 11.15bn | 5.80k | 8.21 | 1.54 | 6.10 | 1.72 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
Shanghai Henlius Biotech Inc | 6.16bn | 756.26m | 11.82bn | 3.55k | 15.67 | 4.20 | 10.19 | 1.92 | 1.39 | 1.39 | 11.29 | 5.18 | 0.5764 | 1.90 | 6.82 | 1,694,066.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 7.60 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
China Traditional Chinese Med Hldg CoLtd | 18.79bn | 1.00bn | 11.99bn | 17.72k | 11.96 | 0.5134 | 5.24 | 0.6378 | 0.199 | 0.199 | 3.73 | 4.64 | 0.453 | 1.54 | 1.82 | 1,086,100.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
Holder | Shares | % Held |
---|---|---|
China Merchants Wealth Asset Management Ltd.as of 09 Oct 2024 | 23.53m | 4.78% |
GF Fund Management Co., Ltd.as of 30 Jun 2024 | 3.52m | 0.72% |
China Asset Management Co., Ltd.as of 30 Jun 2024 | 1.57m | 0.32% |
BlackRock Fund Advisorsas of 03 Oct 2024 | 1.04m | 0.21% |
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 212.60k | 0.04% |
Dimensional Fund Advisors LPas of 31 Jul 2024 | 180.20k | 0.04% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 168.40k | 0.03% |
TIAA-CREF Investment Management LLCas of 31 Aug 2024 | 166.60k | 0.03% |
SSgA Funds Management, Inc.as of 03 Oct 2024 | 124.80k | 0.03% |
China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 99.00k | 0.02% |